EUVIMEDEUVIMED entdecken
Open Access

Structure of human lymphoid-specific helicase HELLS in its autoinhibited state

Gundeep Kaur, Ren Ren, Jisun Lee, John R Horton iD, Xing Zhang, Yang Gao iD, Taiping Chen, Xiaodong Cheng iD

Nucleic Acids Research · 2026

DOI: 10.1093/nar/gkag326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Gundeep Kaur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States. Hauptthemen laut MEDLINE: DNA Helicases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Cancer Prevention and Research Institute of Texas, Baylor College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicase, Lymphoid Specific (HELLS), also known as Lymphoid-Specific Helicase (LSH), is a member of the SNF2 chromatin-remodeling family that regulates DNA methylation and heterochromatin organization. Unlike most chromatin remodelers, HELLS is catalytically inactive in its apo form and requires the DNA-binding protein CDCA7 for activation, though the underlying mechanism has remained unclear. Here, we combine biochemical, biophysical, and cryo-electron microscopy analyses to define the structural basis of HELLS autoinhibition. HELLS alone assembles into a hexameric (trimer of dimers) architecture stabilized by interactions between its N-terminal coiled-coil (CC) domain and ATPase Lobe-1, while ATPase Lobe-2 remains flexible and disengaged. The CC domain functions both as an oligomerization scaffold and as an autoinhibitory module that restricts catalytic activity. Binding of CDCA7 and DNA promotes formation of an active HELLS–CDCA7–DNA ternary complex. CDCA7 recognizes hemimethylated CpG dinucleotides in both B-form and non-B-form DNA and stimulates HELLS ATPase activity. Together, these findings reveal the mechanism of HELLS autoinhibition and its activation by CDCA7 and DNA, providing new insight into how the HELLS–CDCA7–DNA ternary complex maintains DNA methylation and heterochromatin integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA HelicasesHumansDNAModels, MolecularCryoelectron MicroscopyProtein BindingDNA MethylationAdenosine TriphosphatasesProtein MultimerizationProtein Domains

Substanzen

DNA HelicasesDNAHELLS protein, humanAdenosine Triphosphatases

Autor:innen und Institutionen

  • Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Department of Biosciences, Rice University, Houston, TX 77005, United States.

ORCID-Profile: John R Horton, Yang Gao, Xiaodong Cheng

Förderung

  • NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • Baylor College of Medicine
  • Simons Foundation
  • National Institutes of Health

Zitieren

APA

Kaur, G., Ren, R., Lee, J., Horton, J. R., Zhang, X., Gao, Y., Chen, T., & Cheng, X. (2026). Structure of human lymphoid-specific helicase HELLS in its autoinhibited state. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag326

Vancouver

Kaur G, Ren R, Lee J, Horton JR, Zhang X, Gao Y, et al. Structure of human lymphoid-specific helicase HELLS in its autoinhibited state. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag326

BibTeX
@article{Kaur2026,
  author = {Kaur, Gundeep and Ren, Ren and Lee, Jisun and Horton, John R and Zhang, Xing and Gao, Yang and Chen, Taiping and Cheng, Xiaodong},
  title = {Structure of human lymphoid-specific helicase HELLS in its autoinhibited state},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkag326}
}
Kostenlos starten →